GLAXOSMITHKLINE PHARMA A/S: Financial statements 2017
CVR: 27394019
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 426,868,000 and a net result of DKK 9,597,000 compared with DKK 1,872,000 the year before. That is an increase of 16.5% compared with the year before. The profit margin was 2.2%. Equity in the 2017 report amounted to DKK 35,404,000. The solvency ratio was 18.4%. The company had 87 employees in the financial year.
- Revenue
- DKK 426,868,000
- Gross Profit
- DKK 124,391,000
- Profit/Loss
- DKK 9,597,000
- Equity
- DKK 35,404,000
- Total Assets
- DKK 192,045,000
- Employees
- 87
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 426.9 mio. | 124.4 mio. | 9.6 mio. | 35.4 mio. | 87 |
| 2016 | 366.5 mio. | 81.8 mio. | 1.9 mio. | 25.8 mio. | 92 |
| 2015 | 338.9 mio. | 111.7 mio. | 3.7 mio. | 147.9 mio. | 87 |
| 2014 | 371.5 mio. | 119.2 mio. | 11.8 mio. | 144.3 mio. | 92 |
| 2013 | 364.3 mio. | 127 mio. | 14.5 mio. | 146.9 mio. | 109 |
Official annual report
Keep an eye on GLAXOSMITHKLINE PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2016. Revenue came to DKK 366,477,000, and the net result was DKK 1,872,000.
As of April 3, 2017, Josephine Yang Comiskey has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Saskia Fontein has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Daniël Gijbels has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Saskia Fontein is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Josephine Yang Comiskey has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 2, 2017, Josephine Yang Comiskey has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.